Virmani v. Professional Sec. Ins. Co., 2024 WL 446429 (N.C. Ct. App. Feb. 6, 2024).
The North Carolina Court of Appeals confirmed a denial of coverage for a claim the Insured received notice of but failed to report to the insurer until a year and a half later—after the expiration of the policy period.
Read More >>
Zurich Am. Ins. Co. v. Syngenta Crop Prot. LLC, 2024 Del. LEXIS 68 (Feb. 26, 2024).
The Delaware Supreme Court ruled that a plaintiff lawyer’s letter informing a company of potential herbicide injury suits was not a “claim for damages” that an insurer could use to raise a late notice issue and escape its coverage obligations.
Read More >>
In re Ill. Nat. Inc. Co., 2024 Tex. LEXIS 158 (Feb. 23, 2024).
An oil and gas exploration company (the “Company”) settled a class action securities fraud case for the total amount of available insurance proceeds under the policies. Prior to the settlement, the Company’s insurers denied coverage for the action based primarily on untimely notice and refused to advance defense costs.
Read More >>
Pharmacia Corp. N/K/A Pfizer, Inc. v. Arch Specialty Ins. Co., 2024 U.S. App. LEXIS 1280 (3d Cir., Jan. 19, 2024).
As an update to our February publication, the Third Circuit, a high-positioned federal court, has declined a pharmaceutical drug manufacturer’s (the “Manufacturer”) request for an en banc (i.e. special procedure that involves all judges of a court to hear a case at hand) rehearing.
Read More >>
Medical Mut. Ins. Co. v. Gnik, 2024 U.S. App. LEXIS 3697 (4th Cir., Feb. 16, 2024).
The Fourth Circuit affirmed that a health clinic’s founder’s misrepresentation in its insurance application was material and the clinic’s professional liability policy may be rescinded under Virginia state law. Patients sued the clinic and founder for employing an in-house psychologist who was untrained and unlicensed.
Read More >>
Click to read the following cases:
Read More >>
Click to read the following cases:
Read More >>
Click to read the following cases:
Read More >>
Click to read the following cases:
Read More >>
Amtrust Int'l Underwriters Dac v. 180 Life Sciences Corp., 2024 U.S. Dist. LEXIS 24604 (N.D. Cal. Feb. 12, 2024).
A drug development company (the “Company”) sought coverage under its pre-merger D&O policies for former officers’ Defense Costs stemming from an SEC investigation. Following the merger, former officers of the SPAC were subpoenaed in connection with the SEC investigation. The Company advanced a significant amount for Defense Costs, and then sought reimbursement from the SPAC’s D&O carriers. The carriers denied coverage claiming the Company was not an insured under the policy, and, regardless, coverage was barred based on the policy’s Change-In-Control exclusion (the “Exclusion”).
Ultimately, the court determined that the Company was a named insured, the subpoenas were Claims, and the related expenses were Defense Costs constituting Loss. However, the court denied the Company’s request for a coverage determination because it failed to show that the carriers should not rely on the Exclusion to bar coverage. Thus, the Company sought a judgment that the Advancement clause obligated reimbursement pending a coverage determination for the subpoenas.
Under California law, the duty to reimburse is generally limited to covered Claims. However, the language of the policy’s Advancement clause expanded that duty to include potentially covered Claims and provided for payment “prior to final disposition of the Claim.” Given the policy language, the Company argued that “potentially covered” claims triggered the advancement clause. The carriers, however, argued they were only required to advance costs for actually covered Claims and, even if the potentially covered standard applied, the Exclusion barred coverage.
The court agreed with the Company and held that the Advancement clause required the carriers to advance Defense Costs for potentially coverage claims, which included the subpoenas. The court further held that the Exclusion could only apply if the subpoenas alleged, in whole or in part, any Wrongful Acts post-merger. The subpoenas, however, requested documents without any accompanying alleged Wrongful Acts, thus the court was unable to determine definitively whether the SEC was investigating the officers for their pre- or post-merger Wrongful Acts.
The North Carolina Court of Appeals confirmed a denial of coverage for a claim the Insured received notice of but failed to report to the insurer until a year and a half later—after the expiration of the policy period.
Prior to providing notice, a complaint was filed with the state medical board against the Insured doctor in connection with concerns she had regarding the Insured’s inappropriate behavior with some of his patients. The Insured doctor learned he was under investigation. The Insured hired counsel to represent him but did not notify his professional liability insurer for a year and a half. In the interim, the previous professional liability policy covering the doctor had expired.
The Insured’s professional liability policy covered claims made and reported during the policy period. The insurer denied coverage because the Insured was aware of the complaint and investigation but did not report it to the insurer until after the expiration of the policy.
On appeal, the reviewing court held that the policy’s reporting requirements were not ambiguous and required a Claim “to have both arisen during a covered policy term and to be reported within a covered policy term.” As it was undisputed that the Insured failed to provide prompt notice, the court upheld the denial of coverage. The Insured also hired his own counsel, thereby depriving the insurer of its right to select counsel. The court further reasoned that to conclude otherwise would transform the “claims made and reported” policy to an “occurrence policy”—a policy indemnifying the policyholder for any loss from an event that occurs within the policy period, regardless of when a claim is made.
The Delaware Supreme Court ruled that a plaintiff lawyer’s letter informing a company of potential herbicide injury suits was not a “claim for damages” that an insurer could use to raise a late notice issue and escape its coverage obligations. The letter, which was sent one year before the policies at issue were incepted, warned the insured company that the firm was retaining clients who allegedly developed Parkinson’s disease as a result of exposure to the company’s herbicide. Then, during the policy period, several lawsuits were filed. The insurer initially agreed to provide a defense subject to a reservation of rights. However, after receiving a copy of the letter, the insurer filed a coverage action claiming the letter constituted a claim that was made prior to the inception of the policy period.
The court determined that the letter and related communications did not constitute a “claim for damages” under the policies because it did not identify any specific claimants and did not include a demand or request for monetary relief. The vague threat of potential litigation could not satisfy the definition of a claim. This is an example of an insurer taking an inconsistent position. Although it is clear that the letter would never have been accepted as a notice of a claim by an insurer, here, the insurer attempted to use that same letter to avoid coverage. This highlights the critical importance of reaching out to brokers early and often to ensure proper notification of claims and potential claims, even when circumstances indicate an insurer would unlikely accept a given matter as a notice of claim.
Per the settlement agreement, the shareholders would pursue the Company’s interests in the coverage action to fund the settlement, as well as reimburse the Company for its self-funded defense costs. The shareholders agreed to release the Company regardless of the outcome of the litigation. The settlement agreement was approved without objection from the insurers.
The insurers argued the settlement was not binding on them and was inadmissible to establish coverage or the amount of Loss. The court held that an Insured’s legal obligation to pay could be established by a settlement agreement regardless of an admission of liability or a release. However, under Texas law, a settlement is only binding on a liability insurer when it was the result of an adversarial process. Because the Company was released regardless of the outcome, it had no meaningful incentive to ensure the settlement amount represented its potential liability or the shareholders’ actual damages. Rather, the settlement amount was tied solely to the available insurance proceeds with no consideration of the losses suffered by the shareholders. The Company and shareholders could not rely on the agreement as evidence of coverage or amount of Loss.
As an update to our February publication, the Third Circuit, a high-positioned federal court, has declined a pharmaceutical drug manufacturer’s (the “Manufacturer”) request for an en banc (i.e. special procedure that involves all judges of a court to hear a case at hand) rehearing. The Manufacturer was seeking indemnification for a settlement agreement reached in a class action lawsuit in which the Manufacturer was accused of artificially inflating stock prices by misrepresenting the results of a clinical drug study.
In its request for an en banc rehearing, the Manufacturer argued that "[b]y holding that excess attachment required each underlying insurer to pay its limit and to separately and affirmatively 'admit liability' for the claim, the panel gave no regard to the practical implications of its interpretation that rendered recovery under the excess policy 'impossible.'" The Third Circuit denied the Manufacturer’s request for a rehearing because no judge on the panel sought a rehearing and the majority of the judges within the circuit also did not vote in favor of a rehearing.
The Fourth Circuit affirmed that a health clinic’s founder’s misrepresentation in its insurance application was material and the clinic’s professional liability policy may be rescinded under Virginia state law. Patients sued the clinic and founder for employing an in-house psychologist who was untrained and unlicensed. Although the clinic asked for proof of credentials and licensing before hiring, the employee provided only a fake diploma, which the clinic allegedly accepted without further investigation. After the employee began working as a psychologist, the state regulatory board investigated her for practicing without a license; however, the investigation was resolved as “undetermined.”
Following the investigation, the clinic applied for professional liability insurance. The application included a question regarding whether the applicant or any employees had been the subject of “disciplinary investigative proceedings.” The founder answered “no” and the policy was issued. During the initial policy period, the clinic filed claims based on subsequent complaints stemming from the psychologist’s alleged fraud. The carrier paid some expenses and later renewed the policy, albeit at a higher premium. The psychologist was eventually arrested and convicted of fraud. The conviction was followed by the civil lawsuits at issue.
The insureds sought coverage from their professional liability carrier, who in turn filed a declaratory judgment action to rescind the policy based on a material misrepresentation in the insurance application. The lower court found that the misstatement was material. The decision was appealed. The Insureds argued there was a question whether the founder knew their answer on the application was false and whether the answer was material.
Under Virginia law, an insurer may rescind a policy if they can prove the insured made a material misstatement in the policy application. A misstatement is material if it would reasonably influence a carrier’s decision to issue a policy or to increase the premium. The court held the founder’s subjective knowledge concerning her statement was irrelevant because in Virginia, unless the statement was made “to the best of [the applicant’s] knowledge,” proof of falsity is sufficient regardless of intent. The application question unambiguously encompassed the investigation pre-dating the application and therefore the statement was false. As to materiality, the court inferred that because the carrier increased its premium upon renewal, it likely would have done the same if the application was answered truthfully, making the misstatement a material one.
A California appellate court recently ruled in favor of the state’s privacy protection agency (“the Agency”) holding that the California Privacy Rights Act of 2020 (“the Act”) is currently enforceable. The court rejected the state’s Chamber of Commerce (“the Chamber”) argument that, based upon the plain wording of the Act, the Agency was required to develop regulations for the state to administer the Act and then wait a year from the regulations being finalized to begin enforcement.
On February 21, 2024, United Health Group (the “Company”) experienced a cyberattack (the “attack”) that allowed threat actors to gain access to the Company’s technology unit, Change Healthcare’s (“Change Healthcare”) information technology systems.
A class action lawsuit recently filed against a pharmaceutical company (the “Company”), as well as its Pensions and Benefits Committee and individual committee members may foreshadow future litigation. The suit contained allegations of breach of fiduciary duties and other violations of ERISA in the management of the Company’s group health plan.
For its fiscal year 2023 (“2023 fiscal year”) the EEOC recovered more than $665 million for employment discrimination victims. This record-breaking recovery reflects a 29.5% increase over the past year and an increased demand for the EEOC’s services and proposed remedies for victims of employment discrimination.
In a recent order (the “Order”) issued by the SEC, several broker-dealers and investment advisers (the “Firms”) were charged with widespread failures to maintain and preserve electronic communications by the Firms and their employees.
A pharmaceutical company (the “Company”) that developed a medical product (the “Product”) to treat a rare disorder was entitled to coverage under its Directors and Officers policy for a class action lawsuit.
In a narrowly decided vote, the SEC finalized a new set of climate reporting standards (the “New Rule”). Despite the threat of litigation, the New Rule is a scaled-back version of climate reporting standards that were proposed nearly two years ago.
Director/Officer | Role | Company |
Paul A. Pereira | Former CEO/ Founder | Alfi, Inc. |
Director/Officer |
Role |
Company |
Paul A. Pereira |
Former CEO/Founder |
Alfi, Inc. |
Amount |
Director/Officer |
Role |
Company |
$1,825, 318 |
Brian Sewell |
Founder |
Rockwell Capital Management |
$2,101,939.51 |
John Feloni |
CEO |
Stock Squirrel, Inc. |
$14,099,645 |
L. Rose, S. Shelby, and K, Dirden |
Directors |
SHE Beverage Company, Inc. |
$2,000,431 |
Jatinder Bhogal |
COO |
RenovaCare, Inc. |
Amount |
Director/Officer |
Role |
Company |
$1,825,318 |
Brian Sewell |
Founder |
Rockwell Capital Management |
$2,101,939.51 |
John Feloni |
CEO |
Stock Squirrel, Inc. |
$14,099,645 |
L. Rose, S. Shelby, and K, Dirden |
Directors |
SHE Beverage Company, Inc. |
$2,000,431 |
Jatinder Bhogal |
COO |
RenovaCare, Inc. |
https://www.sec.gov/litigation/admin.htm
Source: Stanford Law School Securities Class Action Clearinghouse
Abbe Darr, Esq.
Claims Attorney
abbe.darr@alliant.com
David Finz, Esq.
Claims Attorney
david.finz@alliant.com
Isabel Arustamyan, Esq.
Claims Attorney
isabel.arustamyan@alliant.com
Jacqueline Vinar, Esq.
Claims Attorney
jacqueline.vinar@alliant.com
Jaimi Berliner, Esq.
Claims Attorney
jaimi.berliner@alliant.com
Karina Montoya, J.D.
Claims Advocate
karina.montoya@alliant.com
Malia Shappell, Esq.
Claims Attorney
malia.shappell@alliant.com
Michael Radak, Esq.
Claims Attorney
michael.radak@alliant.com
Peter Kelly, Esq.
Claims Attorney
peter.kelly@alliant.com
Robert Aratingi
Senior Claims Advocate
robert.aratingi@alliant.com
Steve Levine, Esq.
Claims Attorney
slevine@alliant.com